• Amarin Corp. plc, of Dublin, was issued U.S. Patent notice of allowance No. 13/417,899, "Pharmaceutical Compositions Comprising EPA and a Cardiovascular Agent and Methods of Using the Same." The application covers the use of Vascepa (icosapent ethyl) and statin therapy to reduce triglycerides.